# Study of the Safety, Tolerability and Pharmacokinetics of HZ-A-018 in Patients With B Cell Lymphoma

> **NCT04173455** · PHASE1 · UNKNOWN · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 46 (estimated)

## Conditions studied

- Lymphoma, B-Cell

## Interventions

- **DRUG:** HZ-A-018

## Key facts

- **NCT ID:** NCT04173455
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-28
- **Primary completion:** 2021-09
- **Final completion:** 2022-02
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2019-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04173455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04173455, "Study of the Safety, Tolerability and Pharmacokinetics of HZ-A-018 in Patients With B Cell Lymphoma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04173455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*